Login / Signup
Amy E Stewart
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 3
Top Topics
Clinical Trial
Cell Therapy
Circulating Tumor
Dna Damage Response
Top Venues
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Tona M Gilmer
,
Chun-Hsiang Lai
,
Kexiao Guo
,
Katherine Deland
,
Kathleen A Ashcraft
,
Amy E Stewart
,
Yaode Wang
,
Jianmin Fu
,
Kris C Wood
,
David G Kirsch
,
Michael B Kastan
A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors.
Molecular cancer therapeutics
23 (6) (2024)
Tona M Gilmer
,
Chun-Hsiang Lai
,
Kexiao Guo
,
Katherine Deland
,
Kathleen A Ashcraft
,
Amy E Stewart
,
Yaode Wang
,
Jianmin Fu
,
Kris C Wood
,
David G Kirsch
,
Michael B Kastan
A novel dual ATM/DNA-PK inhibitor, XRD-0394, potently radiosensitizes and potentiates PARP and topoisomerase I inhibitors.
Molecular cancer therapeutics
(2024)
Tona M Gilmer
,
Chun-Hsiang Lai
,
Kexiao Guo
,
Katherine Deland
,
Kathleen A Ashcraft
,
Amy E Stewart
,
Yaode Wang
,
Jianmin Fu
,
Kris C Wood
,
David G Kirsch
,
Michael B Kastan
A Novel Dual ATM/DNA-PK Inhibitor, XRD-0394, Potently Radiosensitizes and Potentiates PARP and Topoisomerase I Inhibitors.
Molecular cancer therapeutics
23 (6) (2024)